藥物釋放型球囊市場規模、佔有率和成長分析：按適應症、塗層劑、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球藥物釋放型球囊市值為 8.5375 億美元，預計到 2025 年將成長至 9.2265 億美元，到 2033 年將成長至 17.1663 億美元，在預測期（2026-2033 年）內複合年成長率為 8.07%。

全球藥物釋放型球囊市場的發展主要受臨床需求驅動，即預防血管成形術後血管再血管再阻塞，其地位已從支架的輔助手段轉變為首選替代方案。這些特殊球囊在擴張過程中可將紫杉醇和Sirolimus等抗增殖藥物直接輸送至血管壁，有效解決血管再阻塞和小血管疾病等複雜病例，且無需植入永久性植入。此外，越來越多的臨床證據表明其具有顯著的衛生經濟效益，這正在塑造市場格局，影響著臨床醫生的選擇和支付方的政策。塗層技術的改進和新型Sirolimus製劑的出現增強了人們的信心，並推動了藥物洗脫球囊的更廣泛應用。此外，人工智慧的進步正在提升病變評估、患者選擇和手術支援能力，從而改善臨床療效。這些因素正在加速藥物藥物釋放型球囊融入常規介入治療，以鞏固其作為一種可行的無植入方案的地位。

全球藥物釋放型球囊市場按適應症、塗層劑衍生物、終端用戶、分銷管道和地區進行細分。依適應症分類，市場分為周邊動脈疾病和冠狀動脈疾病。依塗層劑衍生物分類，市場分為紫杉醇洗脫球囊和Sirolimus洗脫球囊。按終端用戶分類，市場分為「醫院和心臟中心」和「門診手術中心」。依分銷管道分類，市場分為「直銷」與「間接銷售」。依地區分類，市場分為「北美」、「歐洲」、「亞太」、「拉丁美洲」以及「中東和非洲」。

全球藥物釋放型球囊市場的成長要素

隨著臨床醫生在各種血管治療中越來越傾向於使用藥物洗脫球囊，全球藥物釋放型球囊市場正經歷顯著成長。這一趨勢的促進因素包括臨床療效的改善以及介入醫生信心的增強，從而促使人們對藥物洗脫球囊的應用產生更大的興趣。藥物釋放型球囊具有標靶抗增殖作用，無需植入永久性植入即可給藥，簡化了未來的治療方案。這與微創手術的目標相契合，進一步推動了藥物洗脫球囊的普及。隨著醫療專業人員致力於實現長期血管通暢性和減少併發症，藥物釋放型球囊正成為治療方案、培訓計劃和醫院採購中不可或缺的一部分。

全球藥物釋放型球囊市場的限制因素

儘管藥物釋放型球囊具有臨床優勢，但全球市場仍面臨許多挑戰。高昂的手術費用和有限的報銷選擇會對醫療機構和醫療系統造成沉重的經濟負擔。因此，如果購買和手術成本超過現有替代療法的成本，醫院可能會對採用藥物釋放型球囊猶豫不決。這種經濟壓力促使支付方和醫療機構優先考慮成本效益高的解決方案，從而可能阻礙這些設備的常規使用。此外，專業培訓的需求以及對現有臨床流程進行調整的可能性進一步加劇了經濟負擔。這導致決策者採取更保守的做法，減緩了藥物釋放型球囊在臨床實踐中的廣泛應用。

全球藥物釋放型球囊市場趨勢

全球藥物釋放型球囊市場正呈現顯著成長趨勢，其在周邊血管介入治療的應用日益廣泛。臨床醫師越來越傾向於採用這些標靶性強、血管保護性強的治療方法，以最大限度地減少再次治療的需求。製造商不斷創新器械設計和輸送機制，以適應不同病變的解剖結構；同時，醫療機構也在實施相關方案和培訓計劃，以促進介入手術室中藥物洗脫球囊的使用。這種發展趨勢不僅提高了不同動脈區域手術的柔軟性，也促進了不同醫學專科之間的合作。此外，這一趨勢也推動了針對特定適應症的臨床舉措和商業策略的投資，旨在改善患者就醫途徑並確保治療效果的一致性。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球藥物釋放型球囊市場規模：依適應症分類

• 周邊動脈疾病
  • 股膕動脈病變
  • 膝蓋以下部位的病變
• 缺血性心臟疾病
  • 支架內再血管再阻塞
  • 小血管疾病

全球藥物釋放型球囊市場規模：依塗層劑衍生物分類

• 紫杉醇洗脫球囊
• Sirolimus洗脫球囊

全球藥物釋放型球囊市場規模：依最終用戶分類

• 醫院和心臟中心
• 門診手術中心

全球藥物釋放型球囊市場規模：依通路分類

• 直接的
• 間接

全球藥物釋放型球囊市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Boston Scientific Corporation
• B. Braun SE
• BD
• Cook Medical
• Stryker Corporation
• Terumo Corporation
• Asahi Intecc
• MicroPort Scientific Corporation
• Lepu Medical Technology
• Acrostak
• Biotronik
• Cardionovum
• Concept Medical
• Eurocor Tech
• Hexacath
• Minvasys
• OrbusNeich
• Surmodics
• Teleflex

結論與建議

Global Drug Eluting Balloons Market size was valued at USD 853.75 Million in 2024 and is poised to grow from USD 922.65 Million in 2025 to USD 1716.63 Million by 2033, growing at a CAGR of 8.07% during the forecast period (2026-2033).

The global drug-eluting balloons market is significantly influenced by the clinical demand to prevent restenosis following angioplasty, evolving from a supplementary option to a preferred counterpart for stents. These specialized balloons deliver antiproliferative agents like paclitaxel or sirolimus directly to the vessel wall during dilation, addressing complex cases such as in-stent restenosis and small vessel disease without leaving permanent implants. The market is further shaped by accumulating clinical evidence demonstrating health economic benefits, which affect clinician choices and payer policies. Enhanced coating technologies and new sirolimus formulations are bolstering confidence and enabling greater adoption. Moreover, AI advancements are improving clinical outcomes through enhanced lesion assessment, patient selection, and procedural support, fostering deeper integration into routine interventional practices and solidifying drug-eluting balloons as a viable implant-free option.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Eluting Balloons market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Eluting Balloons Market Segments Analysis

The global drug eluting balloons market is segmented by application indication, coating drug derivative, end-user, distribution channel and region. Based on application indication, the market is segmented into Peripheral Artery Disease and Coronary Artery Disease. Based on coating drug derivative, the market is segmented into Paclitaxel Eluting Balloons and Sirolimus Eluting Balloons. Based on end-user, the market is segmented into Hospitals & Cardiac Centers and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Eluting Balloons Market

The Global Drug Eluting Balloons market is experiencing significant growth as clinicians increasingly favor these devices for various vascular procedures. The trend is driven by improved clinical outcomes and enhanced confidence among interventionalists, leading to a greater interest in their use. Drug-eluting balloons offer a targeted antiproliferative effect, allowing physicians to administer medication without leaving a permanent implant, which simplifies future treatment options. This aligns with the goals of minimally invasive procedures, further promoting their adoption. As medical professionals strive for long-lasting vessel patency and fewer complications, drug-eluting balloons are becoming integral to treatment protocols, training initiatives, and hospital procurement discussions.

Restraints in the Global Drug Eluting Balloons Market

The Global Drug Eluting Balloons market faces significant challenges despite the clinical advantages they offer. The high costs associated with procedures and limited reimbursement options can burden healthcare providers and systems financially. Consequently, hospitals may hesitate to adopt drug eluting balloons if their purchase and procedural expenses exceed those of established alternative therapies. This financial pressure often leads payers and providers to prioritize cost-effective solutions, which can stall the routine use of these devices. Additionally, the necessity for specialized training and potential adjustments to existing care pathways further exacerbate the economic strain, causing decision-makers to take a more conservative approach and delaying widespread acceptance of drug eluting balloons in clinical practice.

Market Trends of the Global Drug Eluting Balloons Market

The Global Drug Eluting Balloons market is witnessing a significant trend towards broader adoption in peripheral vascular interventions. Clinicians increasingly prefer these targeted, vessel-preserving treatments to minimize the necessity for repeat procedures. Manufacturers are innovating device designs and delivery mechanisms tailored to various lesion anatomies, while healthcare institutions implement protocols and training programs to enhance their utilization in intervention suites. This evolving landscape not only improves procedural flexibility across diverse arterial beds but also fosters collaboration among medical specialties. Additionally, it drives investment into indication-specific clinical initiatives and commercial strategies aimed at enhancing patient access and ensuring consistent treatment outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Drug Eluting Balloons Market Size by Application Indication & CAGR (2026-2033)

• Market Overview
• Peripheral Artery Disease
  • Femoropopliteal Lesions
  • Infrapopliteal Lesions
• Coronary Artery Disease
  • In-Stent Restenosis
  • Small Vessel Disease

Global Drug Eluting Balloons Market Size by Coating Drug Derivative & CAGR (2026-2033)

• Market Overview
• Paclitaxel Eluting Balloons
• Sirolimus Eluting Balloons

Global Drug Eluting Balloons Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers

Global Drug Eluting Balloons Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct
• Indirect

Global Drug Eluting Balloons Market Size & CAGR (2026-2033)

• North America (Application Indication, Coating Drug Derivative, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Application Indication, Coating Drug Derivative, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application Indication, Coating Drug Derivative, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application Indication, Coating Drug Derivative, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application Indication, Coating Drug Derivative, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acrostak
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concept Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurocor Tech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hexacath
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minvasys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrbusNeich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surmodics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations